Dr Camille Carroll is an academic consultant neurologist at Plymouth University Peninsula Schools of Medicine and Dentistry.
She undertook preclinical medical training, with an intercalated PhD, at the University of Manchester and completed her clinical training at the University of Oxford in 1997.
In 2007 Dr Carroll was awarded a Medical Research Council fellowship. This allowed her to develop research interests investigating neuroprotective mechanisms in cell culture models of Parkinson's disease.
Her current focus is on early disease detection and clinical trials of neuroprotective interventions in Parkinson's disease (PD), currently being the chief investigator of a multi-centre clinical trial of simvastatin as a potential neuroprotective therapy in PD. She is also interested in the use of technology (wearable sensors and apps) for early disease detection, personalising therapy and monitoring disease progression.
She has overseen the development of a PD DNA bank (2700 samples) and a regional PD clinical research register. She leads development of the Parkinson’s disease service in Plymouth and is Chair of the Peninsula Parkinson’s Excellence Network.
She was appointed National Specialty Lead for Neurodegenerative Disease in 2017. This subspecialty includes PD, Motor Neurone Disease (MND) and Huntington's Disease (HD).